KONTAN.CO.ID - JAKARTA. Lippo Group's performance in 2023 still received significant support from the health sector, especially reflected in the performance of PT Lippo Karawaci Tbk (LPKR). Quoting information disclosure at the Indonesia Stock Exchange (IDX), LPKR recorded a satisfactory performance in 2023. The net profit recorded by LPKR reached IDR 50.14 billion, reversing from a loss of IDR 2.69 trillion in 2022. LPKR's revenue also showed a significant increase, reaching IDR 16.99 trillion in 2023, up 14.1% from the previous year which was IDR 14.80 trillion.
If detailed, the largest revenue came from the health business segment which contributed IDR 11.19 trillion, followed by the real estate development business segment of IDR 4.54 trillion, and the lifestyle segment of IDR 1.25 trillion. Baca Juga: Stock Recommendations: Astra International's Performance is Predicted to Grow However, several subsidiaries of the Lippo Group showed varied performance. For example, PT Siloam International Hospitals Tbk (SILO) recorded a net profit of IDR 1.21 trillion, up 73.91% compared to the previous year which was IDR 696.49 billion, with net revenue reaching IDR 11.19 trillion, up 17.57% from the previous year. Meanwhile, PT Matahari Department Store Tbk (LPPF) recorded revenue of IDR 6.53 trillion in 2023, growing 1.30% from the previous year, but LPPF's profit decreased by 51.17% from the previous year to IDR 675.36 billion. On the other hand, PT Lippo Karawaci Tbk (LPCK) recorded revenue of IDR 1.04 trillion, down 15.68% from the previous year, and profit fell 47.63% annually to IDR 161.92 billion, due to a decrease in home sales. Pilarmas Investindo Securities analyst Arinda Izzaty sees SILO's outpatient visits grew 23% YoY and inpatient grew 15.5% YoY. The increase in SILO's profit was also supported by the changing lifestyle of the community after the Covid-19 Pandemic.
